{"url_path":"/sec/rytm/8-k/2026-06-25/item-2","section_key":"item-2","section_title":"Item 2 Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-25","source_url":"https://www.sec.gov/Archives/edgar/data/1649904/0001628280-26-045569-index.html","accession_number":"0001628280-26-045569","cik":"0001649904","ticker":"RYTM","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649904/0001628280-26-045569-index.html","primary_entity_key":"0001649904","primary_entity_name":"RHYTHM PHARMACEUTICALS, INC."},"word_count":33,"has_tables":true,"body_markdown":"Item 2 - Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026.\n\nVotes FORVotes AGAINSTVotes ABSTAINEDBroker Non-Votes\n\n63,924,852197,70123,5930"}